(Q42241285)

19 October 2017

title

Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway (English)

1 reference

19 October 2017

1 reference

Jia-Jia Zhou

1

1 reference

19 October 2017

Ru-Fu Chen

2

1 reference

19 October 2017

Xiao-Geng Deng

3

1 reference

19 October 2017

Yu Zhou

4

1 reference

19 October 2017

Xiao Ye

5

1 reference

19 October 2017

Min Yu

6

1 reference

19 October 2017

Jing Tang

7

1 reference

19 October 2017

Xiao-Yu He

8

1 reference

19 October 2017

Di Cheng

9

1 reference

19 October 2017

Bing Zeng

10

1 reference

19 October 2017

Quan-bo Zhou

11

1 reference

19 October 2017

Zhi-hua Li

12

1 reference

19 October 2017

language of work or name

English

0 references

publication date

21 January 2014

1 reference

19 October 2017

1 reference

19 October 2017

volume

588

1 reference

19 October 2017

issue

4

1 reference

19 October 2017

page(s)

566-573

1 reference

Molecular biology of hepatitis C virus

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

STAT3 signaling: anticancer strategies and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Rational siRNA design for RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Functional evidence that the self-renewal gene NANOG regulates human tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Malignant transformation of 293 cells induced by ectopic expression of human Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Expression of Nanog gene promotes NIH3T3 cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

Small molecule inhibitors of STAT3 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.041

10.1016/J.FEBSLET.2013.11.041

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference